News >

Molecular Testing Essential in NSCLC Management

Brittany Cote
Published: Tuesday, Feb 18, 2020

Jean Lopategui, MD, associate professor of pathology and director of Molecular Genetics Pathology Fellowship at Cedars-Sinai

Jean Lopategui, MD,

Assessing for molecular abnormalities is an essential component in the diagnosis and management of patients with non–small cell lung cancer (NSCLC), explained Jean Lopategui, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication